Lenith Cheng

Dr. Lenith Cheng

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in British Journal of Radiology
Verified
Journal Article
Closed access
CTCharlene Yu Lin Tang
Charlene Yu Lin Tang
WCWei Ming Chua
Wei Ming Chua
LCLenith Cheng
Lenith Cheng
WFWarren Fong
Warren Fong
SZSumbul Zaheer
Sumbul Zaheer
WLWinnie Lam
Winnie Lam
Immunoglobulin G4-related disease (IgG4-RD) was not recognised as a systemic condition until 2003, when extra pancreatic manifestations were identified in patients with autoimmune pancreatitis. Since then, IgG4-RD has been described to involve virtually every organ system. It is highly responsive to immunosuppressants but can have detrimental effects if left untreated. Early recognition of the disease is, therefore, critical. The diagnosis of IgG4-RD is frequently challenging owing to its non-specific clinical manifestations, indolent nature and broad differential diagnoses. Although histopathological examination remains the cornerstone of diagnosis, imaging plays an important role in establishing extent of disease and identifying areas suitable for biopsy. 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) has been demonstrated to be useful in assessing organ involvement, guiding biopsy and monitoring disease response. The 18F-FDG PET/CT scan is highly sensitive and able to evaluate multiorgan involvement in a single examination, a key advantage over conventional imaging modalities. A potential pitfall is its low specificity. As such, detailed knowledge of the imaging findings in IgG4-related disease is required to avoid misdiagnosis. This pictorial review aims to depict the diverse spectrum of imaging findings of IgG4-RD and the key imaging features to distinguish it from other important differential diagnoses.

2 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
AWAlvin Wong
Alvin Wong
BVBalamurugan Vellayappan
Balamurugan Vellayappan
LCLenith Cheng
Lenith Cheng
JZJoseph J Zhao
Joseph J Zhao
VMVaishnavi Muthu
Vaishnavi Muthu
YTYee-Liang Thian
Yee-Liang Thian
Background: Atypical response patterns have been a topic of increasing relevance since the advent of immune checkpoint inhibitors (ICIs), challenging the traditional RECIST (Response Evaluation Criteria in Solid Tumors) method of tumor response assessment. Newer immune-related response criteria can allow for the evolution of radiologic pseudoprogression, but still fail to capture the full range of atypical response patterns encountered in clinical reporting. Methods: We did a detailed lesion-by-lesion analysis of the serial imaging of 46 renal cell carcinoma (RCC) patients treated with ICIs with the aim of capturing the full range of radiologic behaviour. Results: Atypical response patterns observed included pseudoprogression (n = 15; 32.6%), serial pseudoprogression (n = 4; 8.7%), dissociated response (n = 22; 47.8%), abscopal response (n = 9; 19.6%), late response (n = 5; 10.9%), and durable response after cessation of immunotherapy (n = 2; 4.3%). Twenty-four of 46 patients (52.2%) had at least one atypical response pattern and 18 patients (39.1%) had multiple atypical response patterns. Conclusions: There is a high incidence of atypical response patterns in RCC patients receiving ICIs and the study contributes to the growing literature on the abscopal effect. The recognition of these interesting and overlapping radiologic patterns challenges the oncologist to tweak treatment options such that the clinical benefits of ICIs are potentially maximized.

9 June 2020 in Proceedings of Singapore Healthcare
Verified
Journal Article
Open access
PDF file
LCLenith Cheng
Lenith Cheng
WPWee Ming Peh
Wee Ming Peh
WLWinnie Lam
Winnie Lam
The coronavirus disease 2019 outbreak has been designated a public-health emergency in major cities around the globe. Major health-care institutions are scrambling to implement effective infection control measures to ensure the safety of patients and visitors while minimising disruptions to the provision of quality health care. We describe the measures taken by the nuclear medicine units in the major health-care institutions within Singapore to ensure optimal delivery of care to our paediatric patients and their caregivers.

31 July 2019 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
LCLenith Cheng
Lenith Cheng
HHHian Liang Huang
Hian Liang Huang